Global Biodefense Market Insights and Forecast to 2031

Report ID: 1154436 | Published Date: Jan 2025 | No. of Page: 115 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Biodefense Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Anthrax
        1.2.3 Smallpox
        1.2.4 Botulism
        1.2.5 Radiation/Nuclear
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Biodefense Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 US Military Market
        1.3.3 US Civilian Market
        1.3.4 Non - US Market
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Biodefense Market Perspective (2017-2028)
    2.2 Biodefense Growth Trends by Region
        2.2.1 Biodefense Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Biodefense Historic Market Size by Region (2017-2022)
        2.2.3 Biodefense Forecasted Market Size by Region (2023-2028)
    2.3 Biodefense Market Dynamics
        2.3.1 Biodefense Industry Trends
        2.3.2 Biodefense Market Drivers
        2.3.3 Biodefense Market Challenges
        2.3.4 Biodefense Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Biodefense Players by Revenue
        3.1.1 Global Top Biodefense Players by Revenue (2017-2022)
        3.1.2 Global Biodefense Revenue Market Share by Players (2017-2022)
    3.2 Global Biodefense Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Biodefense Revenue
    3.4 Global Biodefense Market Concentration Ratio
        3.4.1 Global Biodefense Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Biodefense Revenue in 2021
    3.5 Biodefense Key Players Head office and Area Served
    3.6 Key Players Biodefense Product Solution and Service
    3.7 Date of Enter into Biodefense Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Biodefense Breakdown Data by Type
    4.1 Global Biodefense Historic Market Size by Type (2017-2022)
    4.2 Global Biodefense Forecasted Market Size by Type (2023-2028)
5 Biodefense Breakdown Data by Application
    5.1 Global Biodefense Historic Market Size by Application (2017-2022)
    5.2 Global Biodefense Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Biodefense Market Size (2017-2028)
    6.2 North America Biodefense Market Size by Type
        6.2.1 North America Biodefense Market Size by Type (2017-2022)
        6.2.2 North America Biodefense Market Size by Type (2023-2028)
        6.2.3 North America Biodefense Market Share by Type (2017-2028)
    6.3 North America Biodefense Market Size by Application
        6.3.1 North America Biodefense Market Size by Application (2017-2022)
        6.3.2 North America Biodefense Market Size by Application (2023-2028)
        6.3.3 North America Biodefense Market Share by Application (2017-2028)
    6.4 North America Biodefense Market Size by Country
        6.4.1 North America Biodefense Market Size by Country (2017-2022)
        6.4.2 North America Biodefense Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Biodefense Market Size (2017-2028)
    7.2 Europe Biodefense Market Size by Type
        7.2.1 Europe Biodefense Market Size by Type (2017-2022)
        7.2.2 Europe Biodefense Market Size by Type (2023-2028)
        7.2.3 Europe Biodefense Market Share by Type (2017-2028)
    7.3 Europe Biodefense Market Size by Application
        7.3.1 Europe Biodefense Market Size by Application (2017-2022)
        7.3.2 Europe Biodefense Market Size by Application (2023-2028)
        7.3.3 Europe Biodefense Market Share by Application (2017-2028)
    7.4 Europe Biodefense Market Size by Country
        7.4.1 Europe Biodefense Market Size by Country (2017-2022)
        7.4.2 Europe Biodefense Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Biodefense Market Size (2017-2028)
    8.2 Asia-Pacific Biodefense Market Size by Type
        8.2.1 Asia-Pacific Biodefense Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Biodefense Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Biodefense Market Share by Type (2017-2028)
    8.3 Asia-Pacific Biodefense Market Size by Application
        8.3.1 Asia-Pacific Biodefense Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Biodefense Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Biodefense Market Share by Application (2017-2028)
    8.4 Asia-Pacific Biodefense Market Size by Region
        8.4.1 Asia-Pacific Biodefense Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Biodefense Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Biodefense Market Size (2017-2028)
    9.2 Latin America Biodefense Market Size by Type
        9.2.1 Latin America Biodefense Market Size by Type (2017-2022)
        9.2.2 Latin America Biodefense Market Size by Type (2023-2028)
        9.2.3 Latin America Biodefense Market Share by Type (2017-2028)
    9.3 Latin America Biodefense Market Size by Application
        9.3.1 Latin America Biodefense Market Size by Application (2017-2022)
        9.3.2 Latin America Biodefense Market Size by Application (2023-2028)
        9.3.3 Latin America Biodefense Market Share by Application (2017-2028)
    9.4 Latin America Biodefense Market Size by Country
        9.4.1 Latin America Biodefense Market Size by Country (2017-2022)
        9.4.2 Latin America Biodefense Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Biodefense Market Size (2017-2028)
    10.2 Middle East & Africa Biodefense Market Size by Type
        10.2.1 Middle East & Africa Biodefense Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Biodefense Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Biodefense Market Share by Type (2017-2028)
    10.3 Middle East & Africa Biodefense Market Size by Application
        10.3.1 Middle East & Africa Biodefense Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Biodefense Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Biodefense Market Share by Application (2017-2028)
    10.4 Middle East & Africa Biodefense Market Size by Country
        10.4.1 Middle East & Africa Biodefense Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Biodefense Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Emergent Biosolutions
        11.1.1 Emergent Biosolutions Company Details
        11.1.2 Emergent Biosolutions Business Overview
        11.1.3 Emergent Biosolutions Biodefense Introduction
        11.1.4 Emergent Biosolutions Revenue in Biodefense Business (2017-2022)
        11.1.5 Emergent Biosolutions Recent Developments
    11.2 Hytest
        11.2.1 Hytest Company Details
        11.2.2 Hytest Business Overview
        11.2.3 Hytest Biodefense Introduction
        11.2.4 Hytest Revenue in Biodefense Business (2017-2022)
        11.2.5 Hytest Recent Developments
    11.3 GSK
        11.3.1 GSK Company Details
        11.3.2 GSK Business Overview
        11.3.3 GSK Biodefense Introduction
        11.3.4 GSK Revenue in Biodefense Business (2017-2022)
        11.3.5 GSK Recent Developments
    11.4 Sanofi
        11.4.1 Sanofi Company Details
        11.4.2 Sanofi Business Overview
        11.4.3 Sanofi Biodefense Introduction
        11.4.4 Sanofi Revenue in Biodefense Business (2017-2022)
        11.4.5 Sanofi Recent Developments
    11.5 PharmAthene
        11.5.1 PharmAthene Company Details
        11.5.2 PharmAthene Business Overview
        11.5.3 PharmAthene Biodefense Introduction
        11.5.4 PharmAthene Revenue in Biodefense Business (2017-2022)
        11.5.5 PharmAthene Recent Developments
    11.6 Bavarian Nordic
        11.6.1 Bavarian Nordic Company Details
        11.6.2 Bavarian Nordic Business Overview
        11.6.3 Bavarian Nordic Biodefense Introduction
        11.6.4 Bavarian Nordic Revenue in Biodefense Business (2017-2022)
        11.6.5 Bavarian Nordic Recent Developments
    11.7 SIGA Technologies
        11.7.1 SIGA Technologies Company Details
        11.7.2 SIGA Technologies Business Overview
        11.7.3 SIGA Technologies Biodefense Introduction
        11.7.4 SIGA Technologies Revenue in Biodefense Business (2017-2022)
        11.7.5 SIGA Technologies Recent Developments
    11.8 Arbutus Biopharma
        11.8.1 Arbutus Biopharma Company Details
        11.8.2 Arbutus Biopharma Business Overview
        11.8.3 Arbutus Biopharma Biodefense Introduction
        11.8.4 Arbutus Biopharma Revenue in Biodefense Business (2017-2022)
        11.8.5 Arbutus Biopharma Recent Developments
    11.9 DynPort Vaccine
        11.9.1 DynPort Vaccine Company Details
        11.9.2 DynPort Vaccine Business Overview
        11.9.3 DynPort Vaccine Biodefense Introduction
        11.9.4 DynPort Vaccine Revenue in Biodefense Business (2017-2022)
        11.9.5 DynPort Vaccine Recent Developments
    11.10 Xoma Corporation
        11.10.1 Xoma Corporation Company Details
        11.10.2 Xoma Corporation Business Overview
        11.10.3 Xoma Corporation Biodefense Introduction
        11.10.4 Xoma Corporation Revenue in Biodefense Business (2017-2022)
        11.10.5 Xoma Corporation Recent Developments
    11.11 Ichor Medical Systems
        11.11.1 Ichor Medical Systems Company Details
        11.11.2 Ichor Medical Systems Business Overview
        11.11.3 Ichor Medical Systems Biodefense Introduction
        11.11.4 Ichor Medical Systems Revenue in Biodefense Business (2017-2022)
        11.11.5 Ichor Medical Systems Recent Developments
    11.12 Aeolus Pharmaceuticals
        11.12.1 Aeolus Pharmaceuticals Company Details
        11.12.2 Aeolus Pharmaceuticals Business Overview
        11.12.3 Aeolus Pharmaceuticals Biodefense Introduction
        11.12.4 Aeolus Pharmaceuticals Revenue in Biodefense Business (2017-2022)
        11.12.5 Aeolus Pharmaceuticals Recent Developments
    11.13 Achaogen
        11.13.1 Achaogen Company Details
        11.13.2 Achaogen Business Overview
        11.13.3 Achaogen Biodefense Introduction
        11.13.4 Achaogen Revenue in Biodefense Business (2017-2022)
        11.13.5 Achaogen Recent Developments
    11.14 Elusys Therapeutics
        11.14.1 Elusys Therapeutics Company Details
        11.14.2 Elusys Therapeutics Business Overview
        11.14.3 Elusys Therapeutics Biodefense Introduction
        11.14.4 Elusys Therapeutics Revenue in Biodefense Business (2017-2022)
        11.14.5 Elusys Therapeutics Recent Developments
    11.15 Dynavax Technologies
        11.15.1 Dynavax Technologies Company Details
        11.15.2 Dynavax Technologies Business Overview
        11.15.3 Dynavax Technologies Biodefense Introduction
        11.15.4 Dynavax Technologies Revenue in Biodefense Business (2017-2022)
        11.15.5 Dynavax Technologies Recent Developments
    11.16 Cleveland BioLabs
        11.16.1 Cleveland BioLabs Company Details
        11.16.2 Cleveland BioLabs Business Overview
        11.16.3 Cleveland BioLabs Biodefense Introduction
        11.16.4 Cleveland BioLabs Revenue in Biodefense Business (2017-2022)
        11.16.5 Cleveland BioLabs Recent Developments
    11.17 Soligenix
        11.17.1 Soligenix Company Details
        11.17.2 Soligenix Business Overview
        11.17.3 Soligenix Biodefense Introduction
        11.17.4 Soligenix Revenue in Biodefense Business (2017-2022)
        11.17.5 Soligenix Recent Developments
    11.18 Alnylam Pharmaceuticals
        11.18.1 Alnylam Pharmaceuticals Company Details
        11.18.2 Alnylam Pharmaceuticals Business Overview
        11.18.3 Alnylam Pharmaceuticals Biodefense Introduction
        11.18.4 Alnylam Pharmaceuticals Revenue in Biodefense Business (2017-2022)
        11.18.5 Alnylam Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Biodefense Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Anthrax
    Table 3. Key Players of Smallpox
    Table 4. Key Players of Botulism
    Table 5. Key Players of Radiation/Nuclear
    Table 6. Key Players of Others
    Table 7. Global Biodefense Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Biodefense Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Biodefense Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Biodefense Market Share by Region (2017-2022)
    Table 11. Global Biodefense Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Biodefense Market Share by Region (2023-2028)
    Table 13. Biodefense Market Trends
    Table 14. Biodefense Market Drivers
    Table 15. Biodefense Market Challenges
    Table 16. Biodefense Market Restraints
    Table 17. Global Biodefense Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Biodefense Revenue Share by Players (2017-2022)
    Table 19. Global Top Biodefense by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biodefense as of 2021)
    Table 20. Ranking of Global Top Biodefense Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Biodefense Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Biodefense Product Solution and Service
    Table 24. Date of Enter into Biodefense Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Biodefense Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Biodefense Revenue Market Share by Type (2017-2022)
    Table 28. Global Biodefense Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Biodefense Revenue Market Share by Type (2023-2028)
    Table 30. Global Biodefense Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Biodefense Revenue Share by Application (2017-2022)
    Table 32. Global Biodefense Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Biodefense Revenue Share by Application (2023-2028)
    Table 34. North America Biodefense Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Biodefense Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Biodefense Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Biodefense Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Biodefense Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Biodefense Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Biodefense Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Biodefense Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Biodefense Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Biodefense Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Biodefense Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Biodefense Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Biodefense Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Biodefense Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Biodefense Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Biodefense Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Biodefense Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Biodefense Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Biodefense Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Biodefense Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Biodefense Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Biodefense Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Biodefense Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Biodefense Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Biodefense Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Biodefense Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Biodefense Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Biodefense Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Biodefense Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Biodefense Market Size by Country (2023-2028) & (US$ Million)
    Table 64. Emergent Biosolutions Company Details
    Table 65. Emergent Biosolutions Business Overview
    Table 66. Emergent Biosolutions Biodefense Product
    Table 67. Emergent Biosolutions Revenue in Biodefense Business (2017-2022) & (US$ Million)
    Table 68. Emergent Biosolutions Recent Developments
    Table 69. Hytest Company Details
    Table 70. Hytest Business Overview
    Table 71. Hytest Biodefense Product
    Table 72. Hytest Revenue in Biodefense Business (2017-2022) & (US$ Million)
    Table 73. Hytest Recent Developments
    Table 74. GSK Company Details
    Table 75. GSK Business Overview
    Table 76. GSK Biodefense Product
    Table 77. GSK Revenue in Biodefense Business (2017-2022) & (US$ Million)
    Table 78. GSK Recent Developments
    Table 79. Sanofi Company Details
    Table 80. Sanofi Business Overview
    Table 81. Sanofi Biodefense Product
    Table 82. Sanofi Revenue in Biodefense Business (2017-2022) & (US$ Million)
    Table 83. Sanofi Recent Developments
    Table 84. PharmAthene Company Details
    Table 85. PharmAthene Business Overview
    Table 86. PharmAthene Biodefense Product
    Table 87. PharmAthene Revenue in Biodefense Business (2017-2022) & (US$ Million)
    Table 88. PharmAthene Recent Developments
    Table 89. Bavarian Nordic Company Details
    Table 90. Bavarian Nordic Business Overview
    Table 91. Bavarian Nordic Biodefense Product
    Table 92. Bavarian Nordic Revenue in Biodefense Business (2017-2022) & (US$ Million)
    Table 93. Bavarian Nordic Recent Developments
    Table 94. SIGA Technologies Company Details
    Table 95. SIGA Technologies Business Overview
    Table 96. SIGA Technologies Biodefense Product
    Table 97. SIGA Technologies Revenue in Biodefense Business (2017-2022) & (US$ Million)
    Table 98. SIGA Technologies Recent Developments
    Table 99. Arbutus Biopharma Company Details
    Table 100. Arbutus Biopharma Business Overview
    Table 101. Arbutus Biopharma Biodefense Product
    Table 102. Arbutus Biopharma Revenue in Biodefense Business (2017-2022) & (US$ Million)
    Table 103. Arbutus Biopharma Recent Developments
    Table 104. DynPort Vaccine Company Details
    Table 105. DynPort Vaccine Business Overview
    Table 106. DynPort Vaccine Biodefense Product
    Table 107. DynPort Vaccine Revenue in Biodefense Business (2017-2022) & (US$ Million)
    Table 108. DynPort Vaccine Recent Developments
    Table 109. Xoma Corporation Company Details
    Table 110. Xoma Corporation Business Overview
    Table 111. Xoma Corporation Biodefense Product
    Table 112. Xoma Corporation Revenue in Biodefense Business (2017-2022) & (US$ Million)
    Table 113. Xoma Corporation Recent Developments
    Table 114. Ichor Medical Systems Company Details
    Table 115. Ichor Medical Systems Business Overview
    Table 116. Ichor Medical Systems Biodefense Product
    Table 117. Ichor Medical Systems Revenue in Biodefense Business (2017-2022) & (US$ Million)
    Table 118. Ichor Medical Systems Recent Developments
    Table 119. Aeolus Pharmaceuticals Company Details
    Table 120. Aeolus Pharmaceuticals Business Overview
    Table 121. Aeolus Pharmaceuticals Biodefense Product
    Table 122. Aeolus Pharmaceuticals Revenue in Biodefense Business (2017-2022) & (US$ Million)
    Table 123. Aeolus Pharmaceuticals Recent Developments
    Table 124. Achaogen Company Details
    Table 125. Achaogen Business Overview
    Table 126. Achaogen Biodefense Product
    Table 127. Achaogen Revenue in Biodefense Business (2017-2022) & (US$ Million)
    Table 128. Achaogen Recent Developments
    Table 129. Elusys Therapeutics Company Details
    Table 130. Elusys Therapeutics Business Overview
    Table 131. Elusys Therapeutics Biodefense Product
    Table 132. Elusys Therapeutics Revenue in Biodefense Business (2017-2022) & (US$ Million)
    Table 133. Elusys Therapeutics Recent Developments
    Table 134. Dynavax Technologies Company Details
    Table 135. Dynavax Technologies Business Overview
    Table 136. Dynavax Technologies Biodefense Product
    Table 137. Dynavax Technologies Revenue in Biodefense Business (2017-2022) & (US$ Million)
    Table 138. Dynavax Technologies Recent Developments
    Table 139. Cleveland BioLabs Company Details
    Table 140. Cleveland BioLabs Business Overview
    Table 141. Cleveland BioLabs Biodefense Product
    Table 142. Cleveland BioLabs Revenue in Biodefense Business (2017-2022) & (US$ Million)
    Table 143. Cleveland BioLabs Recent Developments
    Table 144. Soligenix Company Details
    Table 145. Soligenix Business Overview
    Table 146. Soligenix Biodefense Product
    Table 147. Soligenix Revenue in Biodefense Business (2017-2022) & (US$ Million)
    Table 148. Soligenix Recent Developments
    Table 149. Alnylam Pharmaceuticals Company Details
    Table 150. Alnylam Pharmaceuticals Business Overview
    Table 151. Alnylam Pharmaceuticals Biodefense Product
    Table 152. Alnylam Pharmaceuticals Revenue in Biodefense Business (2017-2022) & (US$ Million)
    Table 153. Alnylam Pharmaceuticals Recent Developments
    Table 154. Research Programs/Design for This Report
    Table 155. Key Data Information from Secondary Sources
    Table 156. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biodefense Market Share by Type: 2021 VS 2028
    Figure 2. Anthrax Features
    Figure 3. Smallpox Features
    Figure 4. Botulism Features
    Figure 5. Radiation/Nuclear Features
    Figure 6. Others Features
    Figure 7. Global Biodefense Market Share by Application: 2021 VS 2028
    Figure 8. US Military Market Case Studies
    Figure 9. US Civilian Market Case Studies
    Figure 10. Non - US Market Case Studies
    Figure 11. Biodefense Report Years Considered
    Figure 12. Global Biodefense Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Biodefense Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Biodefense Market Share by Region: 2021 VS 2028
    Figure 15. Global Biodefense Market Share by Players in 2021
    Figure 16. Global Top Biodefense Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biodefense as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Biodefense Revenue in 2021
    Figure 18. North America Biodefense Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Biodefense Market Size Market Share by Type (2017-2028)
    Figure 20. North America Biodefense Market Size Market Share by Application (2017-2028)
    Figure 21. North America Biodefense Market Size Share by Country (2017-2028)
    Figure 22. United States Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Biodefense Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Biodefense Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Biodefense Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Biodefense Market Size Share by Country (2017-2028)
    Figure 28. Germany Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Biodefense Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Biodefense Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Biodefense Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Biodefense Market Size Share by Region (2017-2028)
    Figure 38. China Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Latin America Biodefense Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Biodefense Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Biodefense Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Biodefense Market Size Share by Country (2017-2028)
    Figure 48. Mexico Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Biodefense Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Biodefense Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Biodefense Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Biodefense Market Size Share by Country (2017-2028)
    Figure 54. Turkey Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Emergent Biosolutions Revenue Growth Rate in Biodefense Business (2017-2022)
    Figure 58. Hytest Revenue Growth Rate in Biodefense Business (2017-2022)
    Figure 59. GSK Revenue Growth Rate in Biodefense Business (2017-2022)
    Figure 60. Sanofi Revenue Growth Rate in Biodefense Business (2017-2022)
    Figure 61. PharmAthene Revenue Growth Rate in Biodefense Business (2017-2022)
    Figure 62. Bavarian Nordic Revenue Growth Rate in Biodefense Business (2017-2022)
    Figure 63. SIGA Technologies Revenue Growth Rate in Biodefense Business (2017-2022)
    Figure 64. Arbutus Biopharma Revenue Growth Rate in Biodefense Business (2017-2022)
    Figure 65. DynPort Vaccine Revenue Growth Rate in Biodefense Business (2017-2022)
    Figure 66. Xoma Corporation Revenue Growth Rate in Biodefense Business (2017-2022)
    Figure 67. Ichor Medical Systems Revenue Growth Rate in Biodefense Business (2017-2022)
    Figure 68. Aeolus Pharmaceuticals Revenue Growth Rate in Biodefense Business (2017-2022)
    Figure 69. Achaogen Revenue Growth Rate in Biodefense Business (2017-2022)
    Figure 70. Elusys Therapeutics Revenue Growth Rate in Biodefense Business (2017-2022)
    Figure 71. Dynavax Technologies Revenue Growth Rate in Biodefense Business (2017-2022)
    Figure 72. Cleveland BioLabs Revenue Growth Rate in Biodefense Business (2017-2022)
    Figure 73. Soligenix Revenue Growth Rate in Biodefense Business (2017-2022)
    Figure 74. Alnylam Pharmaceuticals Revenue Growth Rate in Biodefense Business (2017-2022)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
Frequently Asked Questions
Biodefense report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biodefense report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biodefense report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Glyoxal

Glyoxal market is segmented by Type and by Application. Players, stakeholders, and other particip ... Read More

Sanitary Pottery

Sanitary Pottery market is segmented by Type and by Application. Players, stakeholders, and other ... Read More